Search results for "Opioid use disorder"


 
Results 1 - 10 of about 57 for "Opioid use disorder".
Sort by: Relevance | Newest | Oldest

Low back pain patients with opioid use disorder more likely to get more opioids

One-quarter of Medicare beneficiaries seeking care for acute low back pain received opioid prescriptions, according to 2016 to 2019 data. Patients with opioid use disorder received higher opioid doses and were more likely to be coprescribed gabapentin.
https://immattersacp.org/weekly/archives/2024/06/11/4.htm
11 Jun 2024

New 'weighs' to treat obesity

Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024

Routine opioid use disorder screening fails to significantly increase new diagnosis rates

This may be due to the sensitivity of the screening instrument, compounded by the stigma of opioid use disorder; addressing the latter may increase the instrument's sensitivity, the authors suggest.
https://immattersacp.org/weekly/archives/2023/10/17/2.htm
17 Oct 2023

Telehealth visits may improve outcomes for opioid use disorder

A cross-sectional study of U.S. insurance claims found that buprenorphine initiation during a telehealth visit was associated with a 36% lower overdose rate than in person and that patients in the former group were more likely to refill their prescriptions.
https://immattersacp.org/weekly/archives/2023/09/12/1.htm
12 Sep 2023

Learn the latest on excessive alcohol use, opioid use disorder

This month's issue addresses alcohol use and misuse, prescribing buprenorphine, and improving health care's response to future pandemics.
https://immattersacp.org/archives/2023/03/learn-the-latest-on-excessive-alcohol-use-opioid-use-disorder.htm
1 Mar 2023

One-third of primary care physicians do not support medications for opioid use disorder

Fewer than a quarter of surveyed primary care physicians expressed interest in treating patients with opioid use disorder, and only 11.8% were interested in obtaining a waiver to prescribe buprenorphine.
https://immattersacp.org/weekly/archives/2020/04/21/2.htm
21 Apr 2020

Big barrier to buprenorphine removed

The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023

MKSAP Quiz: 3-year history of pain in muscles, joints

A 47-year-old woman is evaluated for a 3-year history of pain in all of her muscles and joints. She is a commercial truck driver. Her sleep is poor, and she awakens unrefreshed. She completes a fibromyalgia diagnostic questionnaire and meets the criteria for fibromyalgia. She has anxiety and depression. Following a physical exam and lab results, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2024/04/02/3.htm
2 Apr 2024

Buprenorphine, cannabis, and other periop challenges

An expert at a recent hospital medicine conference reviewed the latest on perioperative management of medications.
https://immattersacp.org/archives/2024/01/buprenorphine-cannabis-and-other-periop-challenges.htm
1 Jan 2024

Daily medication appears more cost-effective than monthly injections for opioid use disorder

Over 24 weeks, extended-release naltrexone cost an average of $5,317 more than buprenorphine-naloxone, primarily because the former was more expensive and required a longer detoxification period.
https://immattersacp.org/weekly/archives/2018/12/18/1.htm
18 Dec 2018

Result Page: Prev   1   2   3   4   5   6   Next